Rapport Therapeutics (RAPP) Stock Chart & Stock Price History $14.70 -0.24 (-1.61%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$14.71 +0.01 (+0.07%) As of 08/15/2025 05:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Rapport Therapeutics Stock Price Performance The Rapport Therapeutics (RAPP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 29.36%, with a year-to-date return of -17.14%. In the past month, the stock has decreased 3.42%, reflecting recent market activity. As of the latest close, Rapport Therapeutics traded at $14.70 with a market cap of $536.55 million and volume of 146,287 shares. Receive RAPP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.48%1 Month Performance-3.42%3 Month Performance+47.59%Year-To-Date Performance-17.14%1 Year Performance-29.36% RAPP Stock Chart for Saturday, August, 16, 2025 RAPP Chart by TradingView Rapport Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$14.94$14.70-1.61%$16.41$14.65146,287 shs$536.55 million08/14/2025$15.60$14.94-4.23%$15.44$14.70109,059 shs$545.28 million08/13/2025$15.54$15.60+0.39%$16.13$15.42145,383 shs$569.40 million08/12/2025$14.34$15.54+8.34%$15.87$14.28213,509 shs$567.21 million08/11/2025$14.55$14.34-1.42%$15.49$14.09165,822 shs$523.53 million08/08/2025$15.41$14.55-5.58%$16.00$14.55104,519 shs$531.08 million08/07/2025$14.61$15.41+5.48%$15.60$13.62334,257 shs$562.43 million08/06/2025$14.43$14.61+1.25%$15.88$14.03107,424 shs$533.27 million08/05/2025$14.04$14.43+2.78%$15.20$13.87206,792 shs$526.70 million08/04/2025$14.15$14.04-0.78%$14.88$13.93143,799 shs$512.43 million Get the Latest News and Ratings for RAPP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/01/2025$14.36$14.15-1.46%$15.06$13.88124,280 shs$516.45 million07/31/2025$14.83$14.36-3.17%$15.75$14.16115,222 shs$524.14 million07/30/2025$15.42$14.83-3.83%$15.94$14.42122,920 shs$541.30 million07/29/2025$16.74$15.42-7.89%$17.05$15.30213,219 shs$562.80 million07/28/2025$16.05$16.74+4.30%$17.45$15.82136,616 shs$611.01 million07/25/2025$16.62$16.05-3.43%$16.74$15.44138,147 shs$585.83 million07/24/2025$15.50$16.62+7.23%$17.24$15.20188,703 shs$606.63 million07/23/2025$15.20$15.50+1.97%$15.72$14.86166,390 shs$565.72 million07/22/2025$14.39$15.20+5.63%$15.22$14.10199,905 shs$554.80 million07/21/2025$14.68$14.39-1.98%$15.89$14.34151,103 shs$525.24 million07/18/2025$14.84$14.68-1.08%$15.91$14.52137,409 shs$535.82 million07/17/2025$15.22$14.84-2.50%$16.32$14.60215,146 shs$541.63 million07/16/2025$14.38$15.22+5.84%$15.36$14.24141,978 shs$555.53 million07/15/2025$14.63$14.38-1.71%$15.06$13.43180,924 shs$524.87 million Related Companies AGIO Stock Chart DNLI Stock Chart IDYA Stock Chart TARS Stock Chart IRON Stock Chart HRMY Stock Chart MESO Stock Chart CGON Stock Chart ADPT Stock Chart VCEL Stock Chart Receive RAPP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RAPP) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rapport Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rapport Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access